|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1999-12-17
|
|
pubmed:abstractText |
To determine the safety and efficacy of anabolic therapy to prevent or reverse wasting and malnutrition in human immunodeficiency virus (HIV)-infected pediatric patients. The anabolic steroid, oxandrolone, was evaluated because of its safe and effective use in other pediatric conditions.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1098-4275
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
104
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
e73
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10586007-Adolescent,
pubmed-meshheading:10586007-Anabolic Agents,
pubmed-meshheading:10586007-Body Weight,
pubmed-meshheading:10586007-CD4 Lymphocyte Count,
pubmed-meshheading:10586007-Chi-Square Distribution,
pubmed-meshheading:10586007-Child,
pubmed-meshheading:10586007-Child, Preschool,
pubmed-meshheading:10586007-Child Nutrition Disorders,
pubmed-meshheading:10586007-Female,
pubmed-meshheading:10586007-HIV Seropositivity,
pubmed-meshheading:10586007-HIV Wasting Syndrome,
pubmed-meshheading:10586007-Humans,
pubmed-meshheading:10586007-Male,
pubmed-meshheading:10586007-Oxandrolone,
pubmed-meshheading:10586007-Prospective Studies,
pubmed-meshheading:10586007-Quality of Life,
pubmed-meshheading:10586007-RNA, Viral
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Evaluation of the effects of oxandrolone on malnourished HIV-positive pediatric patients.
|
|
pubmed:affiliation |
Divisions of Clinical Immunology and Allergy, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA. sfox@chla.usc.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
